Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care

BACKGROUND: Fractional exhaled nitric oxide (FeNO) is a surrogate marker of eosinophilic airway inflammation and good predictor of corticosteroid response. AIM: To evaluate how FeNO is being used to guide primary care asthma management in the United Kingdom (UK) with a view to devising practical alg...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, David, Ryan, Dermot, Burden, Annie, Von Ziegenweidt, Julie, Gould, Shuna, Freeman, Daryl, Gruffydd-Jones, Kevin, Copland, Anne, Godley, Clifford, Chisholm, Alison, Thomas, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826517/
https://www.ncbi.nlm.nih.gov/pubmed/24195942
http://dx.doi.org/10.1186/2045-7022-3-37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826517/
https://www.ncbi.nlm.nih.gov/pubmed/24195942
http://dx.doi.org/10.1186/2045-7022-3-37

Ejemplares similares